Interferon β treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology

OBJECTIVE—The ability of recombinant human interferon β-1a (rh-IFN β-1a) to suppress multiple sclerosis activity, evaluated from MRI, was assessed across a range of lesions enhancing at different gadolinium-DTPA (Gd) doses and with different sizes.
METHODS—Every 4 weeks, standard dose (Sd; 0.1 mmol/...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Filippi, M, Rovaris, M, Capra, R, Gasperini, C, Prandini, F, Martinelli, V, Horsfield, M, Bastianello, S, Sormani, M, Pozzilli, C, Comi, G
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 1999
Assuntos:
Short Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1736516/
https://ncbi.nlm.nih.gov/pubmed/10449565
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares